S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE2
MS-275 in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
- Status
- UNKNOWN
- Phase
- PHASE2
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- N/A
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
- Status
- UNKNOWN
- Phase
- PHASE2
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
- Status
- COMPLETED
- Phase
- PHASE2
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PS-341 in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
- Status
- COMPLETED
- Phase
- PHASE1